Jyoti Patel MD FASCO

Professor in Medicine-Hematology/Oncology, Northwestern University Medical School

676 N. St. ClairSuite 850Chicago, IL 60610
Phone+1 312-695-6180
Fax+1 312-695-0990

Dr. Patel is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Patel's full profile Already have an account?

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1996 - 2000
Indiana University School of MedicineClass of 1996

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

IL State Medical License 1998 - 2029
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
Super Doctor SuperDoctors.com

Clinical Trials

Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer
COMPLETED
PHASE2
A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib
COMPLETED
PHASE1, PHASE2
Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer
TERMINATED
PHASE2, PHASE3

Publications & Presentations

PubMed

2 citations
Efficacy of Mobocertinib and Amivantamab in Patients With Advanced Non-Small Cell Lung Cancer With EGFR Exon 20 Insertions Previously Treated With Platinum-Based Chemo...
Sai-Hong Ignatius Ou, Thibaud Prawitz, Huamao M Lin, Jin-Liern Hong, Min Tan
Clinical Lung Cancer. 2024-05-01
1 citations
Addition of Trastuzumab Deruxtecan to Selpercatinib in a Patient With RET Fusion-Driven NSCLC and an Acquired HER2 Amplification: Case Report.
Chetan V Vakkalagadda, Jyoti D Patel
JTO Clinical and Research Reports. 2023-12-01
3 citations
Phase II Randomized Trial of Carboplatin, Pemetrexed, and Bevacizumab With and Without Atezolizumab in Stage IV Nonsquamous Non-Small-Cell Lung Cancer Patients Who Har...
J Nicholas Bodor, Jyoti D Patel, Heather A Wakelee, Benjamin P Levy, Hossein Borghaei
Clinical Lung Cancer. 2023-11-01

Press Mentions

Immunotherapy May Soon Be First-Line Tx for Advanced NSCLCJuly 2nd, 2016
E-cigarette Users Often Believe Devices Will Help Them Quit Tobacco - US NewsJune 4th, 2015
Whole Brain Radiation More Harmful Than Beneficial for Small Brain MetastasesMay 31st, 2015